Extralevator with vs nonextralevator abdominoperineal excision for rectal cancer: the RELAPe randomized controlled trial.
F BiancoG RomanoP TsarkovG StanojevicK ShroyerS GiuratrabocchettaRoberto Bergamaschinull nullPublished in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2018)
ELAPE was associated with statistically improved CRM with no difference in IOP and complication rates compared with non-ELAPE for rectal cancer involving the external anal sphincter.